The multifaceted role of a-to-i rna editing in tumorigenesis: from coding to noncoding RNAs

Abstract RNA editing, a post-transcriptional process altering RNA sequences, is crucial in cancer progression. Adenosine-to-inosine (A-to-I) editing, mediated by ADAR enzymes, and cytosine-to-uridine (C-to-U) editing, by APOBEC proteins, diversify the transcriptome and proteome. Dysregulation of RNA editing significantly impacts gene expression, promoting tumorigenesis through alterations in amino acid sequences, transcript stability, and miRNA targeting. Conflicting research highlights the complexity of RNA editing’s role in cancer. While hyper-editing often correlates with editase overexpression and aggressive phenotypes, hypo-editing links to lower expression. Specific RNA editing events, rather than overall levels, offer more precise insights. ADAR1 primarily promotes oncogenesis, while ADAR2 generally acts as a tumor suppressor. ADAR3’s role remains unclear. RNA editing also influences noncoding RNAs, including miRNAs and lncRNAs, affecting their function and stability. A-to-I editing regulates miRNA biogenesis and mRNA-miRNA interactions, altering target gene selection and processing. LncRNAs, susceptible to A-to-I editing, undergo modifications that disrupt crucial molecular interactions, impacting their roles as miRNA sponges and regulators of gene expression. CircRNAs, through ADAR-mediated regulation, contribute to the complexity of RNA editing’s influence on cancer. This review underscores RNA editing’s multifaceted role in cancer, impacting key signaling pathways and immune surveillance. Understanding these mechanisms is vital for developing targeted therapies and improving cancer outcomes.

Authors

Institutions

Publication Details

Journal
Cancer Cell International
Published
2026-11-17
DOI
https://doi.org/10.1186/s12935-026-04475-0
Primary Topic
RNA regulation and disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The multifaceted role of a-to-i rna editing in tumorigenesis: from coding to noncoding RNAs

Nouran Mohamed, Hussein Sabit, Shaimaa E. Abdel-Ghany, Rawan M. Abdelazeem et al.
Cancer Cell International
RNA regulation and disease
article

The multifaceted role of a-to-i rna editing in tumorigenesis: from coding to noncoding RNAs

Nouran Mohamed, Hussein Sabit, Shaimaa E. Abdel-Ghany, Rawan M. Abdelazeem, Aysha Ghazy
article en

Abstract

Abstract RNA editing, a post-transcriptional process altering RNA sequences, is crucial in cancer progression. Adenosine-to-inosine (A-to-I) editing, mediated by ADAR enzymes, and cytosine-to-uridine (C-to-U) editing, by APOBEC proteins, diversify the transcriptome and proteome. Dysregulation of RNA editing significantly impacts gene expression, promoting tumorigenesis through alterations in amino acid sequences, transcript stability, and miRNA targeting. Conflicting research highlights the complexity of RNA editing’s role in cancer. While hyper-editing often correlates with editase overexpression and aggressive phenotypes, hypo-editing links to lower expression. Specific RNA editing events, rather than overall levels, offer more precise insights. ADAR1 primarily promotes oncogenesis, while ADAR2 generally acts as a tumor suppressor. ADAR3’s role remains unclear. RNA editing also influences noncoding RNAs, including miRNAs and lncRNAs, affecting their function and stability. A-to-I editing regulates miRNA biogenesis and mRNA-miRNA interactions, altering target gene selection and processing. LncRNAs, susceptible to A-to-I editing, undergo modifications that disrupt crucial molecular interactions, impacting their roles as miRNA sponges and regulators of gene expression. CircRNAs, through ADAR-mediated regulation, contribute to the complexity of RNA editing’s influence on cancer. This review underscores RNA editing’s multifaceted role in cancer, impacting key signaling pathways and immune surveillance. Understanding these mechanisms is vital for developing targeted therapies and improving cancer outcomes.

Cancer Cell InternationalVol. 26(1)
Misr University for Science and Technology (EG)
RNA regulation and disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon